Banco Santander’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $39.9M | Buy |
1,655,686
+186,421
| +13% | +$4.88M | 0.25% | 63 |
|
|
2026
Q1 | $41.3M | Sell |
1,469,265
-192,707
| -12% | -$5.13M | 0.33% | 46 |
|
|
2025
Q4 | $41.4M | Sell |
1,661,972
-311,163
| -16% | -$7.85M | 0.31% | 53 |
|
|
2025
Q3 | $50.3M | Buy |
1,973,135
+82,854
| +4% | +$2.05M | 0.45% | 35 |
|
|
2025
Q2 | $45.8M | Buy |
1,890,281
+789,775
| +72% | +$18.4M | 0.44% | 38 |
|
|
2025
Q1 | $27.9M | Buy |
1,100,506
+87,714
| +9% | +$2.3M | 0.31% | 54 |
|
|
2024
Q4 | $26.9M | Sell |
1,012,792
-229,674
| -18% | -$6.23M | 0.32% | 51 |
|
|
2024
Q3 | $36M | Sell |
1,242,466
-3,834
| -0.3% | -$112K | 0.42% | 33 |
|
|
2024
Q2 | $34.9M | Sell |
1,246,300
-27,351
| -2% | -$753K | 0.43% | 35 |
|
|
2024
Q1 | $35.3M | Buy |
1,273,651
+18,094
| +1% | +$502K | 0.43% | 33 |
|
|
2023
Q4 | $36.1M | Buy |
1,255,557
+332,695
| +36% | +$10.1M | 0.43% | 32 |
|
|
2023
Q3 | $30.6M | Buy |
922,862
+136,510
| +17% | +$4.83M | 0.43% | 32 |
|
|
2023
Q2 | $28.8M | Buy |
786,352
+103,671
| +15% | +$4.04M | 0.38% | 35 |
|
|
2023
Q1 | $27.9M | Buy |
682,681
+223,110
| +49% | +$9.64M | 0.41% | 28 |
|
|
2022
Q4 | $23.5M | Buy |
459,571
+11,016
| +2% | +$528K | 0.35% | 41 |
|
|
2022
Q3 | $19.6M | Sell |
448,555
-9,085
| -2% | -$441K | 0.26% | 49 |
|
|
2022
Q2 | $24M | Buy |
457,640
+128,971
| +39% | +$6.57M | 0.32% | 44 |
|
|
2022
Q1 | $17M | Buy |
328,669
+24,907
| +8% | +$1.29M | 0.18% | 77 |
|
|
2021
Q4 | $17.9M | Buy |
303,762
+59,239
| +24% | +$2.94M | 0.1% | 70 |
|
|
2021
Q3 | $10.5M | Sell |
244,523
-193,160
| -44% | -$8.56M | 0.06% | 99 |
|
|
2021
Q2 | $17.1M | Buy |
437,683
+25,163
| +6% | +$979K | 0.1% | 58 |
|
|
2021
Q1 | $14.9M | Buy |
412,520
+24,564
| +6% | +$872K | 0.11% | 65 |
|
|
2020
Q4 | $14.3M | Sell |
387,956
-165,105
| -30% | -$6.06M | 0.1% | 64 |
|
|
2020
Q3 | $19.3M | Sell |
553,061
-7,727
| -1% | -$271K | 0.25% | 38 |
|
|
2020
Q2 | $17.4M | Buy |
560,788
+233,422
| +71% | +$7.93M | 0.23% | 38 |
|
|
2020
Q1 | $10.1M | Sell |
327,366
-12,145
| -4% | -$414K | 0.12% | 111 |
|
|
2019
Q4 | $12.6M | Buy |
339,511
+78,587
| +30% | +$2.8M | 0.12% | 82 |
|
|
2019
Q3 | $8.89M | Sell |
260,924
-13,412
| -5% | -$488K | 0.09% | 101 |
|
|
2019
Q2 | $11.3M | Sell |
274,336
-21,602
| -7% | -$858K | 0.11% | 78 |
|
|
2019
Q1 | $11.9M | Sell |
295,938
-21,089
| -7% | -$845K | 0.13% | 82 |
|
|
2018
Q4 | $13.1M | Sell |
317,027
-147,132
| -32% | -$6.11M | 0.17% | 78 |
|
|
2018
Q3 | $19.4M | Buy |
464,159
+133,955
| +41% | +$5.16M | 0.22% | 60 |
|
|
2018
Q2 | $11.4M | Sell |
330,204
-69,601
| -17% | -$2.38M | 0.13% | 90 |
|
|
2018
Q1 | $13.5M | Sell |
399,805
-1,419,252
| -78% | -$48.8M | 0.16% | 95 |
|
|
2017
Q4 | $62.5M | Buy |
1,819,057
+1,702,153
| +1,456% | +$58M | 0.9% | 10 |
|
|
2017
Q3 | $3.95M | Sell |
116,904
-59,404
| -34% | -$1.91M | 0.07% | 104 |
|
|
2017
Q2 | $5.62M | Sell |
176,308
-44,701
| -20% | -$1.41M | 0.11% | 70 |
|
|
2017
Q1 | $7.17M | Sell |
221,009
-64,050
| -22% | -$2.02M | 0.19% | 41 |
|
|
2016
Q4 | $8.19M | Buy |
+285,059
| New | +$8.7M | 0.22% | 34 |
|
Other funds holding PFE
Banco Santander's PFE Position: Q2 2026 in Review
Banco Santander increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $4.88M and bringing the position to 1,655,686 shares worth $39.9M. The position accounts for 0.25% of the portfolio, ranked #63.
Banco Santander first reported a position in PFE in Q4 2016 and has held it in 39 quarters since. The position peaked at $62.5M in Q4 2017. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Banco Santander held 1,655,686 shares of Pfizer worth $39.9M as of Q2 2026.
- Banco Santander bought 186,421 Pfizer shares in Q2 2026, an estimated $4.88M.
- Pfizer made up 0.25% of Banco Santander's portfolio in Q2 2026, its #63 holding.
- Banco Santander first reported a position in Pfizer in Q4 2016 and has held it in 39 quarters since.
- Banco Santander's Pfizer position peaked at $62.5M in Q4 2017.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.